Results
990
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
990 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
TFBANK | SEK 260.00 | -4.4% | 71.1% | SEK 5.6b | SEK 270.67 | PB2.3x | E27.7% | n/a | Banks | ||
2469 | JP¥2,589.00 | -5.9% | 38.1% | JP¥25.7b | JP¥3,600.00 | PE15.8x | E22.8% | 2.3% | Tech | ||
300896 | CN¥161.50 | 0.04% | -50.5% | CN¥48.6b | CN¥312.90 | PE24.6x | E24.9% | 2.1% | Pharmaceuticals & Biotech | ||
RAY B | SEK 139.20 | -0.4% | 95.0% | SEK 4.8b | SEK 195.00 | PE47.4x | E33.6% | 0.5% | Healthcare | ||
TYRES | €8.40 | 8.9% | -1.9% | €1.2b | €7.94 | PE196.2x | E60.0% | 6.6% | Automobiles | ||
ODD | US$39.54 | -0.3% | -25.8% | US$2.3b | US$52.29 | PE31.3x | E19.0% | n/a | Household | ||
GRNG | SEK 130.50 | -3.8% | 24.2% | SEK 13.9b | SEK 155.00 | PE14x | E20.9% | 2.3% | Materials | ||
2755 | CN¥9.47 | -5.0% | 15.1% | CN¥8.8b | CN¥13.00 | PS5.7x | E90.7% | 0% | Pharmaceuticals & Biotech | ||
GVR | €1.40 | 1.6% | 31.6% | €811.9m | €1.75 | PE17.2x | E22.5% | n/a | Consumer Durables | ||
A348210 | ₩55,400.00 | -3.3% | -38.6% | ₩568.7b | ₩96,800.00 | PE14.9x | E21.2% | 0.9% | Semiconductors | ||
BEG | UK£0.99 | -1.5% | -25.0% | UK£155.3m | UK£1.71 | PE106.9x | E53.7% | 4.0% | Commercial Services | ||
4493 | JP¥2,176.00 | -5.1% | -22.0% | JP¥19.9b | JP¥3,520.00 | PE36.1x | E25.1% | n/a | Software | ||
3032 | CN¥8.68 | 3.3% | -39.0% | CN¥3.5b | CN¥12.01 | PS7.8x | E56.5% | 0.2% | Consumer Services | ||
4461 | JP¥3,555.00 | 0.3% | 104.7% | JP¥34.0b | JP¥4,900.00 | PE29x | E30.6% | 2.0% | Materials | ||
300818 | CN¥21.20 | -0.6% | 9.4% | CN¥3.2b | CN¥27.86 | PE24.3x | E28.4% | 0.6% | Capital Goods | ||
2367 | HK$38.50 | -4.6% | 8.9% | HK$38.9b | HK$57.07 | PE24.8x | E22.8% | 1.2% | Household | ||
601127 | CN¥75.62 | -0.7% | 69.1% | CN¥113.9b | CN¥123.05 | PS2x | E44.0% | 0% | Automobiles | ||
ARGX | €466.60 | 8.6% | 0.9% | €27.9b | €486.80 | PS18.2x | E59.4% | n/a | Pharmaceuticals & Biotech | ||
DV | US$21.58 | 5.9% | -39.9% | US$3.5b | US$28.59 | PE55.8x | E20.9% | n/a | Software | ||
DXN | RM 0.66 | 3.1% | -11.5% | RM 3.3b | n/a | PE10.2x | E13.0% | 6.1% | Household | ||
CARA | NOK 17.55 | 10.0% | 9.6% | NOK 1.3b | NOK 26.50 | PS5x | E112.6% | 10.5% | Healthcare | ||
HBIO | US$3.33 | 0.9% | -26.3% | US$136.8m | US$7.00 | PS1.4x | E106.7% | n/a | Pharmaceuticals & Biotech | ||
EDAC | €9.12 | -6.4% | -48.8% | €76.6m | €18.10 | PE12.2x | E27.1% | 1.6% | Capital Goods | ||
MNHLDG | RM 0.93 | -4.6% | 215.3% | RM 432.0m | RM 1.55 | PE29.2x | E29.6% | n/a | Capital Goods |